Stanley Robboy

Professor Emeritus of Pathology
Stanley Robboy
Stanley Robboy

Overview

My research program, largely histopathological, concerns definitions of criteria, biological properties, differential diagnosis, and survival associated with pathological lesions in the female genital tract. With the gynecologic oncologists at Duke, we have reviewed the Institution's long term experience of endometrial cancer and with the International Collaborative Group on Endometrium, we have developed a new classification system for endometrial hyperplasia that better differentiates precancerous from benign lesions. In a nationwide NIH study in which I head the pathology review, long term complications in both sons and daughters from prenatal exposure to DES are being assessed. A major initiative is a study of vulvar dermatoses and unusual vulvar neoplasms. A final clinical pathologic correlation study, ongoing for over 40 years, has been the long term follow-up of a very rare tumor (malignant struma ovarii). Long term study has been required to identify those features that will ultimately prove to be of biologic significance for defining cases which will likely recur.

Positions

Professor Emeritus of Pathology in the School of Medicine

2022 School of Medicine

Vice-Chair for Diagnostic Pathology in the Department of Pathology in the School of Medicine

1998 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

1992 School of Medicine

Education

M.D. 1965

1965 University of Michigan, Ann Arbor

Intern, Pathology

1966 Icahn School of Medicine at Mount Sinai

Chief Resident, Pathology

1970 Massachusetts General Hospital

Publications, Grants & Awards

Offices & Contact

Duke Box 3712
Durham, NC
27710
M227 Davison Bldg
Durham, NC
27710